A detailed history of Sei Investments CO transactions in Grifols Sa stock. As of the latest transaction made, Sei Investments CO holds 2,169,961 shares of GRFS stock, worth $17 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,169,961
Previous 2,209,547 1.79%
Holding current value
$17 Million
Previous $13.9 Million 38.43%
% of portfolio
0.03%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$6.28 - $9.38 $248,600 - $371,316
-39,586 Reduced 1.79%
2,169,961 $19.3 Million
Q2 2024

Aug 13, 2024

BUY
$6.27 - $7.7 $627,821 - $771,008
100,131 Added 4.75%
2,209,547 $13.9 Million
Q1 2024

May 07, 2024

BUY
$5.47 - $11.38 $585,290 - $1.22 Million
107,000 Added 5.34%
2,109,416 $14.1 Million
Q4 2023

Feb 14, 2024

SELL
$7.71 - $11.56 $3,099 - $4,647
-402 Reduced 0.02%
2,002,416 $23.1 Million
Q3 2023

Nov 14, 2023

BUY
$8.91 - $10.91 $11.6 Million - $14.2 Million
1,300,978 Added 185.37%
2,002,818 $18.3 Million
Q2 2023

Aug 11, 2023

BUY
$7.14 - $9.29 $2.83 Million - $3.68 Million
396,600 Added 129.93%
701,840 $6.43 Million
Q1 2023

May 12, 2023

BUY
$6.65 - $10.69 $159,600 - $256,560
24,000 Added 8.53%
305,240 $2.25 Million
Q4 2022

Feb 10, 2023

SELL
$5.96 - $8.53 $1.55 Million - $2.23 Million
-260,860 Reduced 48.12%
281,240 $2.39 Million
Q3 2022

Nov 14, 2022

SELL
$5.95 - $14.3 $232 - $557
-39 Reduced 0.01%
542,100 $3.34 Million
Q1 2022

May 13, 2022

BUY
$10.37 - $12.73 $742,533 - $911,518
71,604 Added 15.22%
542,139 $6.33 Million
Q4 2021

Feb 14, 2022

BUY
$10.21 - $15.27 $623,187 - $932,034
61,037 Added 14.91%
470,535 $5.28 Million
Q3 2021

Nov 12, 2021

BUY
$14.07 - $17.3 $362,991 - $446,322
25,799 Added 6.72%
409,498 $5.98 Million
Q2 2021

Aug 06, 2021

BUY
$16.62 - $18.94 $1,745 - $1,988
105 Added 0.03%
383,699 $6.66 Million
Q1 2021

May 12, 2021

BUY
$15.15 - $19.78 $1.47 Million - $1.92 Million
97,283 Added 33.98%
383,594 $6.64 Million
Q4 2020

Feb 08, 2021

BUY
$16.86 - $19.67 $2.73 Million - $3.18 Million
161,783 Added 129.92%
286,311 $5.28 Million
Q3 2020

Dec 04, 2020

SELL
$15.4 - $20.16 $28,197 - $36,912
-1,831 Reduced 1.45%
124,528 $2.16 Million
Q3 2020

Nov 06, 2020

SELL
$15.4 - $20.16 $4.38 Million - $5.73 Million
-284,211 Reduced 69.22%
126,359 $2.19 Million
Q2 2020

Aug 17, 2020

BUY
$18.24 - $21.45 $4.94 Million - $5.81 Million
270,831 Added 193.81%
410,570 $7.49 Million
Q2 2020

Aug 11, 2020

SELL
$18.24 - $21.45 $321,680 - $378,292
-17,636 Reduced 11.21%
139,739 $3.25 Million
Q1 2020

May 14, 2020

BUY
$16.28 - $25.63 $299,698 - $471,822
18,409 Added 13.25%
157,375 $3.17 Million
Q4 2019

Feb 06, 2020

BUY
$19.57 - $23.52 $195 - $235
10 Added 0.01%
138,966 $3.24 Million
Q3 2019

Nov 12, 2019

SELL
$19.85 - $22.76 $100,341 - $115,051
-5,055 Reduced 3.51%
138,956 $2.79 Million
Q2 2019

Aug 14, 2019

BUY
$17.59 - $21.1 $322,055 - $386,319
18,309 Added 14.57%
144,011 $3.04 Million
Q1 2019

May 15, 2019

BUY
$18.01 - $20.11 $663,092 - $740,409
36,818 Added 41.42%
125,702 $2.53 Million
Q4 2018

Feb 13, 2019

SELL
$17.44 - $21.53 $592 - $732
-34 Reduced 0.04%
88,884 $1.9 Million
Q3 2018

Nov 08, 2018

SELL
$19.97 - $21.96 $16,395 - $18,029
-821 Reduced 0.91%
88,918 $1.9 Million
Q2 2018

Aug 03, 2018

SELL
$20.16 - $24.68 $3.1 Million - $3.8 Million
-153,869 Reduced 63.16%
89,739 $1.93 Million
Q1 2018

May 11, 2018

SELL
$20.31 - $24.95 $4.74 Million - $5.83 Million
-233,484 Reduced 48.94%
243,608 $5.17 Million
Q4 2017

Feb 08, 2018

SELL
$20.99 - $23.89 $1.47 Million - $1.68 Million
-70,244 Reduced 12.83%
477,092 $10.9 Million
Q3 2017

Nov 06, 2017

BUY
$20.07 - $21.89 $11 Million - $12 Million
547,336
547,336 $12 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.